The largest database of trusted experimental protocols

Zorbax sb aq column

Manufactured by Agilent Technologies
Sourced in United States, Japan

The ZORBAX SB-Aq column is a reversed-phase high-performance liquid chromatography (HPLC) column designed for the separation of a wide range of polar and hydrophilic compounds. It features a silica-based stationary phase with an embedded polar group that enhances the retention of polar analytes.

Automatically generated - may contain errors

58 protocols using zorbax sb aq column

1

Quantification of INH and RIF in Skin and Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten microliters of the supernatant from local skin tissues or blood samples was analyzed by HPLC (Agilent 1200, Palo Alto, CA) using Agilent ZORBAX SB-Aq column (4.6 mm × 100 mm, 5 μm) guarded by a ZORBAX SB-Aq column (2.1 mm × 12.5 mm, 5 μm) and detected by a UV2000 ultraviolet detector set at a wavelength of 264 nm for INH and 340 nm for RIF. For INH analysis, the mobile phase consisted of 0.02 M heptanesulfonic acid sodium salt: methanol: acetonitrile (78:17:5, v/v/v) and the column was kept at 25 °C. For RIF analysis, the mobile phase consisted of 0.05 M phosphate buffer: methanol (30:70, v/v) and the column was kept at 25 °C. Standard curves were constructed by dissolving known concentration of INH (1–100 μg/mL) or RIF (2–600 μg/mL) into blank skin homogenates or blank plasma and treating them similar to the experimental samples. Six different concentrations were used for developing a standard curve. The concentration of INH and RIF in each tested sample was calculated on the basis of standard curve. Both of the detection limits of INH and RIF in skin sample or blood sample were 1 μg/mL.
+ Open protocol
+ Expand
2

Comprehensive Spectroscopic Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NMR spectra were obtained on a Varian 500 spectrometer, with deuterated solvent as reference. The optical rotations were determined using an Autopol® IV Automatic polarimeter. The FT-IR spectra were measured using a Nicolet NEXUS-470 infrared spectrometer. HR-ESI-MS spectra were recorded on a Xevo-G2 Q-TOF mass spectrometer with an electrospray ionization (ESI) interface (Waters, Milford, MA, USA) in the negative mode. Analytical HPLC was performed on an Agilent 1100 HPLC system, equipped with a diode array detector and an Agilent ZORBAX SB-Aq column (250 mm×4.6 mm, 5 μm). Semi-preparative HPLC was carried out on an Agilent 1200 instrument, using an Agilent ZORBAX SB-Aq column (250 mm×10 mm, 5 μm), detected at a UV wavelength of 230 nm. Column chromatography (CC) was performed on macroporous resin AB-8 (Cangzhou Bon Adsorber Technology Co.), silica gel (100–200 mesh or 200–300 mesh, Qingdao Haiyang Chemical Works, China), Sephadex LH-20 (Pharmacia Co.), and ODS (Merck). Analytical grade solvents were purchased from Beijing Chemical Factory.
+ Open protocol
+ Expand
3

Foliar Hormone Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The foliar hormone was measured according to Guo et al. (2017) (link) with some modification. Approximately 300 mg of plant tissue was hand ground in liquid nitrogen and was quickly homogenized in 0.5 mL extraction buffer for 30 min at 4°C with gentle agitation on a shaker. Subsequently, each sample was additionally added 1 mL of CH2Cl2, and then agitated for 30 min on a shaker at 4°C. The homogenized sample was centrifuged at 13,000 g for 10 min. After centrifugation, the lower layer was collected, and then was concentrated in a dry machine. The concentrated sample was re-solubilized in 200 μL of MeOH. Next, 1 μL of the sample was injected into an Agilent ZORBAX SB-Aq column (600 bar, 2.1 mm × 100 mm, 1.8 μm) for hormone analysis. The hormone contents were calculated with reference to standard curves.
+ Open protocol
+ Expand
4

Synthesis and Characterization of HBV Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the organic solvents used for the synthesis were of analytical grade. Unless otherwise stated, all chemicals were purchased from Aladdin (Shanghai, China). Melting points were measured on a WRX-4 micro melting point instrument (Shanghai YiCe Equipment, China) and were uncorrected. 1H NMR and 13C NMR spectra were recorded on BRUKER DPX-400 and DPX-600 spectrometers (Bruker Company, Germany), using TMS as an internal standard and CDCl3, MeOD-d4, Pyridine-d5 and DMSO-d6 as solvents. Chemical shifts (δ values) and coupling constants (J values) are given in ppm and Hz, respectively. All the solvents and reactants were of analytical grade and were used without further purification unless noted. Column chromatography was accomplished on silica gel (100–200 or 200–300 mesh, Qingdao, China). The purity of compounds was confirmed to be over 95% and was determined by high performance liquid chromatography (HPLC) with a ZORBAX SB-Aq column (250 mm × 4.6 mm, 5 μm, Agilent) using ACN/water (10%, v/v) as the mobile phase (1.0 mL/min).HepG2.2.15 cells were provided by Beijing 302 Hospital and presented by Prof.Su of Guilin Medical College. HepG2.2.15 cells are hepatoma cell lines capable of expressing HBV antigen and secreting complete HBV particles.
+ Open protocol
+ Expand
5

HPLC Quantification of Phenolic Compounds in Barley

Check if the same lab product or an alternative is used in the 5 most similar protocols
The individual phenolic compounds in the above extracts were quantified using a Shimazu LC-20AD HPLC system. A ZORBAX SB-Aq column (5 m, 4.6 mm × 250 mm ID, Agilent) was used at a column temperature of 30°C. The mobile phase consisted of a 0.1% aqueous solution of formic acid (solution A) and acetonitrile (solution B) with the following gradient program: 0–10 min, solution B 3–3%; 10–20 min, solution B 3–80%; 20–30 min, solution B 80–3%; 30–35 min, solution B 3–3%. Other chromatographic conditions included a constant flow rate of 0.8 ml/min, an injection volume of 20 μL, a run time of 35 min, and a detection wavelength of 254 and 320 nm. Prior to analysis, all samples were filtered through a 0.25–l m membrane filter. The identification of each peak was based on the retention time and the chromatography of authentic standards. The concentrations of each compound were calculated according to a standard curve, and the results were expressed as μg/g DW of barley powder.
+ Open protocol
+ Expand
6

HPLC Analysis of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantitative analysis was performed using an Agilent 1100 system (Agilent, USA). Chromatographic separations were carried out on a Zorbax SB-Aq column (250 mm × 4.6 mm, 5 μm; Agilent, USA), maintained at 35 °C. The mobile phases were acetonitrile (A) and 0.1% (v/v) phosphoric acid (B) (with a gradient elution program of 0–15 min, 12% A; 15–25 min, 13–14% A; 25–30 min, 14% A; 30–40 min, 14%–12% A), at a flow rate of 0.8 mL/min. The injection volume was 5–20 μL each time. The detection wavelength was set to 340 nm.
+ Open protocol
+ Expand
7

Comprehensive Metabolic Profiling Using HILIC and RPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolic extracts were analyzed four times using hydrophilic liquid chromatography (HILIC) and reverse phase liquid chromatography (RPLC) separation in both positive and negative ionization modes as previously described124 (link). Data were acquired on a Thermo Q Exactive plus mass spectrometer equipped with a HESI-II probe and operated in full MS scan mode. MS/MS data were acquired on pool samples consisting of an equimolar mixture of all the samples in the study. HILIC experiments were performed using a ZIC-HILIC column 2.1×100 mm, 3.5μm, 200Å (Merck Millipore) and mobile phase solvents consisting of 10mM ammonium acetate in 50/50 acetonitrile/water (A) and 10 mM ammonium acetate in 95/5 acetonitrile/water (B). RPLC experiments were performed using a Zorbax SBaq column 2.1 × 50 mm, 1.7 μm, 100Å (Agilent Technologies) and mobile phase solvents consisting of 0.06% acetic acid in water (A) and 0.06% acetic acid in methanol (B). Data quality was ensured by (i) injecting 6 and 12-pool samples to equilibrate the LC-MS system prior to run the sequence for RPLC and HILIC, respectively, (ii) sample randomization for metabolite extraction and data acquisition, and (iii) checking mass accuracy, retention time and peak shape of internal standards in every samples.
+ Open protocol
+ Expand
8

Metabolomic Profiling of Serum and Cecal Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
A well-developed metabolomic platform based on the GC/TOF-MS technique was used to profile the metabolites in the serum samples from each group, as previously reported, with a few modifications 26 (link). The amount of serum was reduced to 30 μL and extracted with 120 μL of methanol. The supernatants were dried and derivatized for GC/TOF-MS analysis. For extraction and analysis of metabolites in cecal content, cecal content (0.5 g) were added with 1000 μL purified water and vigorously vortexed for 3 min (1:2, w). An aliquots of 50 μL mixture was transferred to an Eppendorf tube, and then 200μL methanol (containing internal standard [13C2]-myristic acid 5μg/mL) was added and vortexed for 3 min. An aliquot of 100 μL supernatant was dried and derivatized for GC/TOF-MS analysis in the same way as that of serum samples. The raw data acquired with GC/TOF-MS were processed, and the metabolites were identified as previously reported 26 (link). The multivariate data were evaluated using the SIMCA P-13 software (Umetrics, Umeå, Sweden). Bile acids, such as cholic acid(CA), glycocholic acid (GCA), taurocholic acid (TCA), deoxycholic acid(DCA), ursodeoxycholic acid(UDCA), lithocholic acid(LCA) and chenodeoxycholic acid (CDCA) were quantitative analysed in Shimadzu LC/MS 2010, equipped with an Aglient ZORBAX SB-Aq column (2.1 × 150 mm, 3.5 μm), Method S1.
+ Open protocol
+ Expand
9

Quantifying mRNA m6A Modification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclease P1 (1 U; Sigma) in 20 μl of buffer, which contained 10 mM of NH4Ac (pH 5.3), was used to digest mRNA at 42 °C for 4 h. Then, 100 mM NH4HCO3 and alkaline phosphatase (0.5 U) were then added to about 50 to 100 ng purified mRNA for another incubation at 37 °C for 4 h. Next, the supernatant of digested sample was collected by centrifugation (4 °C, 13,000 rpm, 20 min) and then injected into Ultraperformance liquid chromatography-MS/MS. Ultraperformance liquid chromatography (SHIMADZU) equipped with ZORBAX SB-Aq column (Agilent) was used to separate the nucleosides. Then, Triple Quad 5500 (AB SCIEX) in positive ion multiple reaction-monitoring mode was used to detect the nucleosides. According to nucleoside-to-base ion mass transitions, the modifications were quantified: m/z 268.0 to 136.0 for A and m/z 282.0 to 150.1 for m6A. Pure nucleosides were used to generate standard curves. Then, the concentrations of A and m6A in the sample were calculated. Finally, the percentage of total unmodified A represents the level of m6A.
+ Open protocol
+ Expand
10

Quantitative Analysis of CHR and ANT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured broth was centrifuged at 15,000 ×g for 10 min. The supernatant was filtered using a Nylaflo nylon membrane filter and stored at -20°C. The concentrations of CHR and ANT were determined by high-performance liquid chromatography (HPLC) using a Zorbax SB-Aq column (4.6 x 250 mm, Agilent, USA). The mobile phase was 0.1% trifluoroacetic acid (TFA) in 40% MeOH and the flow rate was 0.5 ml/min. CHR and ANT were detected at 273 nm and 330 nm, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!